Mukka Proteins Limited has informed the Exchange about update on Acquisition

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

MUKKA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹29.99

prior close

₹30.13

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.1% vs market

Food Products peers, median of 78sector · industry level-0.1%+0.1% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.1 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.6

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0+0.1-0.1-0.1+0.1

Next day

-0.1-0.1+0.0-0.1+0.1

+0.1-0.0+0.1-0.6+0.7

+0.0+0.4-0.3-0.4+0.5

-0.3-0.1-0.2-0.2-0.1

+0.0-0.2+0.3-0.3+0.3

+0.0+0.6-0.6-0.6+0.6

15d

-1.3+1.5-2.8-0.8-0.5

-7.0-2.7-4.3-4.2-2.8

-10.0-3.8-6.3-4.9-5.1

-10.8-4.1-6.7-5.9-4.9

UpDownMarket · Nifty Microcap 250Sector · Food Products peers, median of 78Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mukka Proteins Limited has informed the exchanges that its previously announced acquisition of FABBCO Bio Cycle and Bio Protein Technology Private Limited has been delayed. The acquisition, originally expected to be completed by 30th June 2025, has now been pushed to 30th September 2025. The company attributed the delay to procedural issues. The acquisition is being executed through a share transfer route, and the company stated that all necessary steps are being taken to address the delays and complete the transaction in due course.

Likely market impact

The three-month delay due to procedural issues introduces short-term uncertainty for shareholders awaiting completion of this strategic investment. However, since the deal has not been called off and the company is actively working to close it, the long-term investment thesis remains intact, though investors should watch for further updates on whether the revised timeline is met.